about
HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community careProvider-Level and Other Health Systems Factors Influencing Engagement in HIV Care: A Qualitative Study of a Vulnerable PopulationThe effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.The exposure assessment in current time study: implementation, feasibility, and acceptability of real-time data collection in a community cohort of illicit drug users.Acceptability of a mobile health intervention to enhance HIV care coordination for patients with substance use disorders.Physician Decisions to Defer Antiretroviral Therapy in Key Populations: Implications for Reducing Human Immunodeficiency Virus Incidence and Mortality in Malaysia.Prospective evaluation of the ability of clinical scoring systems and physician-determined likelihood of appendicitis to obviate the need for CTManifestations of HIV stigma and their impact on retention in care for people transitioning from prisons to communities.HIV and Re-Incarceration: Time for a Comprehensive Approach.Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy.Provider Workforce Assessment in a Rural Hepatitis C Epidemic: Implications for Scale-up of Antiviral Therapy.Capturing illicit drug use where and when it happens: an ecological momentary assessment of the social, physical and activity environment of using versus craving illicit drugsCutaneous manifestations of human immunodeficiency virus: a clinical updateUtilizing mHealth methods to identify patterns of high risk illicit drug use.Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers.High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants.Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs.Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users.Performance of Risk-Based and Birth-Cohort Strategies for Identifying Hepatitis C Virus Infection Among People Entering Prison, Wisconsin, 2014.Emergency Department Patients' Perceptions of Radiation From Medical Imaging.Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users.Using Mobile Health Technology to Improve HIV Care for Persons Living with HIV and Substance Abuse.Racial/ethnic differences in trust in health care: HIV conspiracy beliefs and vaccine research participation.Barriers and facilitators of hepatitis C screening among people who inject drugs: a multi-city, mixed-methods study.Ethical issues in mHealth research involving persons living with HIV/AIDS and substance abuseFrailty and Cause-Specific Hospitalization Among Persons Aging With HIV Infection and Injection Drug Use.Early onset inhalant use and risk for opiate initiation by young adulthood.Developing a Patient Navigation Program to Improve Engagement in HIV Medical Care and Viral Suppression: A Demonstration Project Protocol.Pre-exposure Prophylaxis in Primary Care--A New Era in HIV Prevention.Trends in the Use of Medical Imaging to Diagnose Appendicitis at an Academic Medical Center.Sepsis Survivors Admitted to Skilled Nursing Facilities: Cognitive Impairment, Activities of Daily Living Dependence, and Survival.Idiopathic CD4 lymphocytopenia with giant cell arteritis and pulmonary mucormycosis.Using a Mobile-Health System to Monitor and Provide Support along the Hepatitis C Virus Continuum of Care for People with Opioid Use Disorders: Experience from a Randomized Trial.The continuum of hepatitis C care for criminal justice involved adults in the DAA era: a retrospective cohort study demonstrating limited treatment uptake and inconsistent linkage to community-based care.1530No Decrease in HIV Risk Behaviors among Clients Repeatedly Screened for HIV in a State-Funded Counseling, Testing and Referral Program: Missed Opportunities for Risk-Reduction Interventions?1716Engagement in OutSmart Flu, a smartphone-based surveillance system for influenza-like illness among students on a university campus.Implementing a Standardized Social Networks Testing Strategy in a Low HIV Prevalence Jurisdiction
P50
Q27014885-6115238E-AEE4-4BBD-803E-C00E40EA1BABQ28552668-AF6432D7-4B06-490B-B28D-48F5905B169DQ30831694-28BA9509-A112-4BB0-9A0A-B9C35424A679Q33440320-E898177F-3D77-44B0-A93C-0AA5EA8C64D8Q33454207-46403215-C3F5-4D25-BC35-2DC76B6BC09EQ33629465-44D6B4DA-8C04-4A98-985B-17BA0AE35015Q33725279-F1EA8921-47AE-498C-8FFD-D3E3DAAF1D90Q33769991-7B38BA82-05A5-4EBB-9AAA-53F0CEEB5B43Q34653421-846DAC40-1747-4D4E-8A3D-8B54276D48A0Q34997577-BD33FF37-985E-4E8D-9BD0-C67203E3388AQ35452380-75E72D1E-D938-47D3-821A-4D1DD2135788Q35639889-5C36FCE9-CAA9-4B8A-8389-01C0EAF6ADD2Q35660454-987D4852-D066-4F1B-AEEB-829E123B5ECDQ35660779-4A4EE1EB-826A-42E1-A572-A7A82A167173Q35660947-FE15B415-6E49-4F21-9AF0-EBA8847164C0Q35835854-8E005CC8-DF00-4911-9608-94BE31C8824FQ36728346-1C05F710-C3F4-4173-9318-0159551581F6Q36903236-D4B77C99-908F-47BD-838C-369532E697D2Q36919650-91217004-032D-49C0-BF87-EFCCDBAD4E64Q37075712-0DE55020-4C5B-4912-9976-A6610087556EQ37165542-FB358079-F2DC-44B7-BDAA-11D27467A850Q37227942-29DC5661-64A7-4E43-A611-6C7D8C2245E4Q37408153-683E7F93-A024-4932-86E7-29412F83ADB0Q37471381-545C9E80-6DC9-49EF-A1EB-646ECA00F777Q37496984-705BE23D-5C1D-4D7E-85AD-2CEEBAE67313Q38156440-09DA9372-DB60-4DF1-B16F-72FD482A99CFQ39496803-B8AC4936-952B-48F3-B7A0-91C892E1C489Q39716784-293F1969-AFC4-4275-89F6-4CE9F928D3ADQ40297229-0D97DB90-DF75-4FA9-BA56-2459B6271DE6Q40723562-578F6B6C-E787-4130-8D6D-AC1B22AF0FE3Q40725313-842FCC20-70CB-402F-9EBC-7ABDD43E7D77Q41989642-D3F22EBB-60CE-4DAF-855B-2E152E7BA90AQ42155235-D111D681-B616-444F-BEEC-9ECA056069A5Q47099408-4B87087F-F371-4F76-81DA-BF1A5BDEDB26Q47115868-1C4358FB-EC3F-45C5-89D4-E79D03C6743EQ50334322-C4C9E43E-D5FE-4260-94F6-BAD3B7AE717CQ55033143-B755B42A-3AE3-468D-A7E3-A7C1BDF6CF83Q61451889-A81ABAAB-A6CA-4068-9C28-023C775413F3
P50
name
Ryan P. Westergaard
@ast
Ryan P. Westergaard
@en
Ryan P. Westergaard
@nl
type
label
Ryan P. Westergaard
@ast
Ryan P. Westergaard
@en
Ryan P. Westergaard
@nl
prefLabel
Ryan P. Westergaard
@ast
Ryan P. Westergaard
@en
Ryan P. Westergaard
@nl